• LAST PRICE
    0.1103
  • TODAY'S CHANGE (%)
    Trending Down-0.0016 (-1.4298%)
  • Bid / Lots
    0.1103/ 1
  • Ask / Lots
    0.1120/ 8
  • Open / Previous Close
    0.1117 / 0.1119
  • Day Range
    Low 0.1071
    High 0.1120
  • 52 Week Range
    Low 0.1049
    High 1.8850
  • Volume
    1,433,547
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.1119
TimeVolumeJAGX
09:32 ET78290.111199
09:33 ET27590.1112
09:35 ET9330.1111
09:37 ET94940.111
09:39 ET24410.111
09:44 ET13420.111
09:46 ET207990.1109
09:48 ET23520.110949
09:50 ET214610.1104
09:51 ET273440.109
09:53 ET23560.108
09:55 ET61230.1099
09:57 ET47510.1099
10:00 ET4000.1082
10:02 ET57380.1099
10:06 ET40690.1074
10:08 ET26260.1099
10:09 ET118360.109543
10:13 ET5000.109
10:18 ET334500.1089
10:20 ET2758080.1089
10:22 ET2230.1096
10:24 ET4000.109861
10:26 ET7000.1095
10:27 ET80000.1096
10:29 ET54000.1091
10:31 ET78330.1096
10:33 ET228040.1093
10:36 ET42170.1093
10:38 ET1000.11
10:42 ET335060.1094
10:44 ET1471980.1111
10:45 ET205240.1108
10:51 ET83000.11105
10:54 ET497180.1097
10:56 ET955760.1093
10:58 ET2000.1093
11:00 ET31190.1094
11:02 ET24630.10933
11:03 ET74000.1094
11:05 ET8000.1093
11:07 ET351310.1094
11:09 ET918800.1094
11:12 ET111200.1094
11:14 ET93680.1093
11:16 ET40000.109306
11:18 ET56260.1093
11:20 ET218650.1094
11:21 ET99800.1094
11:27 ET2130.1113
11:30 ET180920.11
11:32 ET212340.11
11:34 ET58800.110165
11:36 ET13160.1109
11:38 ET155090.1102
11:41 ET6000.110295
11:43 ET20120.1103
11:45 ET9500.1102
11:48 ET100000.11025
11:50 ET55700.1101
11:52 ET223000.1102
11:54 ET1920.1102
11:56 ET20410.11019
11:57 ET1920.1101
11:59 ET9540.1101
12:01 ET399390.1102
12:03 ET256810.1101
12:06 ET21000.11
12:08 ET113270.11
12:10 ET2000.1101
12:12 ET299050.1101
12:14 ET183330.1102
12:17 ET8160.1103
12:21 ET2000.1103
12:24 ET1000.1102
12:28 ET19000.1103
12:30 ET10000.11025
12:33 ET1000.1102
12:37 ET13980.1102
12:42 ET18390.1103
12:46 ET4640.1103
12:50 ET3000.1103
12:51 ET5000.1103
12:55 ET7390.1104
12:57 ET4000.1103
01:00 ET19090.1103
01:02 ET251130.112
01:04 ET26490.1104
01:06 ET270760.1103
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesJAGX
Jaguar Health Inc
16.3M
-0.1x
---
United StatesHGEN
Humanigen Inc
15.5M
-0.1x
---
United StatesERYP
Erytech Pharma SA
18.5M
0.0x
---
United StatesPULM
Pulmatrix Inc
14.0M
-0.6x
---
United StatesAEZS
Aeterna Zentaris Inc
18.7M
-1.9x
---
United StatesACRX
AcelRx Pharmaceuticals Inc
14.2M
0.3x
---
As of 2022-12-09

Company Information

Jaguar Health, Inc. is a commercial stage pharmaceutical company. The Company is focused on developing plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with gastrointestinal (GI) distress, including chronic and debilitating diarrhea. The Company operates through two segments: human health and animal health. The animal health segment is focused on developing and commercializing prescription and non-prescription products for companion and production animals. Its Canalevia-CA1 is used for chemotherapy-induced diarrhea in dogs. The human health segment is focused on developing and commercializing of human products and the ongoing commercialization of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) on antiretroviral therapy. Its wholly owned subsidiary is Napo Pharmaceuticals, Inc.

Contact Information

Headquarters
200 PINE STREET SUITE 400SAN FRANCISCO, CA, United States 94104
Phone
415-371-8300
Fax
302-655-5049

Executives

Independent Chairman of the Board
James Bochnowski
President, Chief Executive Officer, Director
Lisa Conte
Chief Financial Officer
Carol Lizak
Chief Scientific Officer
Pravin Chaturvedi
Chief of Staff, General Counsel, Chief Compliance Officer
Jonathan Wolin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$16.3M
Revenue (TTM)
$10.8M
Shares Outstanding
145.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.68
EPS
$-0.79
Book Value
$0.23
P/E Ratio
-0.1x
Price/Sales (TTM)
1.5
Price/Cash Flow (TTM)
---
Operating Margin
-381.76%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.